Cuba in the Netherlands

Embassy visited the stand of the Holland Pro Cuba Foundation

Lisse, September 23, 2024. Representatives of the Cuban Embassy in the Kingdom of the Netherlands visited the stand of the Netherlands Pro Cuba Foundation at the Fruit Fair in Lisse.

During the visit, they exchanged with the president of the Foundation, Guillermo Veldhoven, about a humanitarian project that he is promoting to help the development of sustainable small-scale agriculture.

Cuban ambassador visited supportive friends in Amsterdam

Amsterdam, September 10, 2024. The Cuban ambassador to the Netherlands, Anet Pino Rivero, visited the headquarters of the “Hands off the G77” Group, where she was received by its coordinator George Janszen.

Accompanied by members of the Diplomatic Mission team, the Ambassador thanked the support offered by the Group in defense of the elimination of the genocidal blockade imposed by the United States against Cuba for more than 60 years.

Meeting with Mr. David Wagner and with Mrs. Carole Thoma

Luxembourg, September 5, 2024. The Cuban Ambassador, Anet Pino Rivero, as part of her visit to Luxembourg, held a meeting with Mr. David Wagner, member of the Luxembourg parliament, representative of the Dei Lenk (The Left) party, and with Mrs. Carole Thoma, spokesperson for the same party.

Meeting with Mrs. Veronique Dockendorf

Luxembourg, September 5, 2024. As part of her visit, the Cuban Ambassador, Anet Pino Rivero, held a meeting with the Director of Political Affairs of the Luxembourg Foreign Ministry, Mrs. Veronique Dockendorf.

Cuba present at the Conference on cancer vaccines in the Netherlands

Amsterdam, September 4, 2024. Professor, Dr. Mónica Bequet Romero, from the Center for Genetics and Biotechnology (CIGB), presented the experiences of Cuba at the II Conference on vaccines and immunological treatments against cancer, held in the capital of the Netherlands.

The organizers, professors from the University of Amsterdam, invited the Cuban scientist to give a presentation on Cuban studies and the development of the HEBERSa Vax vaccine, for the treatment of various types of cancer.

Pages